Search

Displaying results 31 - 40 of 198 in total
  1. Pathway

    3-Methylthiofentanyl Action Pathway

    smpdb.ca/view/SMP0000679
    Drug action

    Hyperpolarization of neuron is caused by inactivation of calcium channels and activation of potassium channels via facilitated by G-protein. … The binding of methadyl acetate will eventually lead to reduced pain because of decreased nerve conduction and release of neurotransmitter.

    Drugs: ATP · Norepinephrine · Dopamine · Potassium cation · Calcium · 3-Methylthiofentanyl
    Enzymes: Sodium/potassium-transporting ATPase subunit alpha-1, Sodium/potassium-transporting ATPase subunit beta-1
  2. Pathway

    Dimethylthiambutene Action Pathway

    smpdb.ca/view/SMP0000680
    Drug action

    G(i) protein can also open potassium channels and close calcium channels to result in hyperpolarize on neuron. … Dimethylthiambutene (also known as Ohton or Aminobutene) is an opioid analgesic and substrate for mu-type opioid receptor which can be used for relieving pain.

    Drugs: ATP · Norepinephrine · Dopamine · Potassium cation · Calcium · Dimethylthiambutene
    Enzymes: Sodium/potassium-transporting ATPase subunit alpha-1, Sodium/potassium-transporting ATPase subunit beta-1
  3. Indication

    Dehydration

    go.drugbank.com/conditions/DBCOND0003946
    Drugs: Calcium chloride · D-glucose · Hyaluronic acid · Potassium chloride · Sodium chloride · Sodium citrate +2 more
  4. Pathway

    Oxycodone Action Pathway

    smpdb.ca/view/SMP0000409
    Drug action

    Hyperpolarization of neuron is caused by inactivation of calcium channels and activation of potassium channels via facilitated by G-protein. … The binding of oxycodone will eventually lead to reduced pain because of decreased nerve conduction and release of neurotransmitter.

    Drugs: ATP · Norepinephrine · Oxycodone · Dopamine · Potassium cation · Calcium
    Enzymes: Sodium/potassium-transporting ATPase subunit alpha-1, Sodium/potassium-transporting ATPase subunit beta-1
  5. Pathway

    Fentanyl Action Pathway

    smpdb.ca/view/SMP0000415
    Drug action

    Hyperpolarization of neuron is caused by inactivation of calcium channels and activation of potassium channels via facilitated by G-protein. … The binding of carfentanil will eventually lead to reduced pain because of decreased nerve conduction and release of neurotransmitter.

    Drugs: ATP · Norepinephrine · Fentanyl · Dopamine · Potassium cation · Calcium
    Enzymes: Sodium/potassium-transporting ATPase subunit alpha-1, Sodium/potassium-transporting ATPase subunit beta-1
  6. Pathway

    Dezocine Action Pathway

    smpdb.ca/view/SMP0000676
    Drug action

    Hyperpolarization of neuron is caused by inactivation of calcium channels and activation of potassium channels via facilitated by G-protein. … The binding of dezocine will eventually lead to reduced pain because of decreased nerve conduction and release of neurotransmitter.

    Drugs: ATP · Norepinephrine · Dopamine · Dezocine · Potassium cation · Calcium
    Enzymes: Sodium/potassium-transporting ATPase subunit alpha-1, Sodium/potassium-transporting ATPase subunit beta-1
  7. Pathway

    Dihydromorphine Action Pathway

    smpdb.ca/view/SMP0000689
    Drug action

    Hyperpolarization of neuron is caused by inactivation of calcium channels and activation of potassium channels via facilitated by G-protein. … The binding of dihydromorphine acetate will eventually lead to reduced pain because of decreased nerve conduction and release of neurotransmitter.

    Drugs: ATP · Norepinephrine · Dopamine · Potassium cation · Calcium · Dihydromorphine
    Enzymes: Sodium/potassium-transporting ATPase subunit alpha-1, Sodium/potassium-transporting ATPase subunit beta-1
  8. Pathway

    Ketobemidone Action Pathway

    smpdb.ca/view/SMP0000690
    Drug action

    Hyperpolarization of neuron is caused by inactivation of calcium channels and activation of potassium channels via facilitated by G-protein. … The binding of ketobemidone acetate will eventually lead to reduced pain because of decreased nerve conduction and release of neurotransmitter.

    Drugs: ATP · Norepinephrine · Dopamine · Potassium cation · Calcium · Ketobemidone
    Enzymes: Sodium/potassium-transporting ATPase subunit alpha-1, Sodium/potassium-transporting ATPase subunit beta-1
  9. Pathway

    Hydromorphone Action Pathway

    smpdb.ca/view/SMP0000410
    Drug action

    Hyperpolarization of neuron is caused by inactivation of calcium channels and activation of potassium channels via facilitated by G-protein. … The binding of hydromorphone will eventually lead to reduced pain because of decreased nerve conduction and release of neurotransmitter.

    Drugs: ATP · Hydromorphone · Norepinephrine · Dopamine · Potassium cation · Calcium
    Enzymes: Sodium/potassium-transporting ATPase subunit alpha-1, Sodium/potassium-transporting ATPase subunit beta-1
  10. Pathway

    Hydrocodone Action Pathway

    smpdb.ca/view/SMP0000411
    Drug action

    Hyperpolarization of neuron is caused by inactivation of calcium channels and activation of potassium channels via facilitated by G-protein. … The binding of hydrocodone will eventually lead to reduced pain because of decreased nerve conduction and release of neurotransmitter.

    Drugs: ATP · Norepinephrine · Hydrocodone · Dopamine · Potassium cation · Calcium
    Enzymes: Sodium/potassium-transporting ATPase subunit alpha-1, Sodium/potassium-transporting ATPase subunit beta-1